O. Wildner
Clinical Gene Therapy Branch/National Human Genome Research Institute
NIH, Bethesda
Maryland 20892-1851
USA
Name/email consistency: high
- Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer. Wildner, O., Blaese, R.M., Candotti, F. Cancer Res. (1999)
- Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan. Wildner, O., Blaese, R.M., Morris, J.C. Hum. Gene Ther. (1999)
- In situ use of suicide genes for therapy of brain tumours. Wildner, O. Ann. Med. (1999)
- Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. Wildner, O., Blaese, R.M., Morris, J.C. Cancer Res. (1999)









